OCS
Price
$18.07
Change
-$0.13 (-0.71%)
Updated
Aug 8, 10:30 AM (EDT)
Capitalization
928.81M
PRAX
Price
$46.52
Change
-$0.74 (-1.57%)
Updated
Aug 8, 10:51 AM (EDT)
Capitalization
994.83M
89 days until earnings call
Interact to see
Advertisement

OCS vs PRAX

Header iconOCS vs PRAX Comparison
Open Charts OCS vs PRAXBanner chart's image
Oculis Holding AG
Price$18.07
Change-$0.13 (-0.71%)
VolumeN/A
Capitalization928.81M
Praxis Precision Medicines
Price$46.52
Change-$0.74 (-1.57%)
Volume$300
Capitalization994.83M
OCS vs PRAX Comparison Chart in %
Loading...
OCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OCS vs. PRAX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OCS is a Buy and PRAX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (OCS: $18.20 vs. PRAX: $47.27)
Brand notoriety: OCS and PRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OCS: 26% vs. PRAX: 56%
Market capitalization -- OCS: $928.81M vs. PRAX: $994.83M
OCS [@Biotechnology] is valued at $928.81M. PRAX’s [@Biotechnology] market capitalization is $994.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OCS’s FA Score shows that 0 FA rating(s) are green whilePRAX’s FA Score has 0 green FA rating(s).

  • OCS’s FA Score: 0 green, 5 red.
  • PRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, both OCS and PRAX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OCS’s TA Score shows that 6 TA indicator(s) are bullish while PRAX’s TA Score has 4 bullish TA indicator(s).

  • OCS’s TA Score: 6 bullish, 4 bearish.
  • PRAX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, OCS is a better buy in the short-term than PRAX.

Price Growth

OCS (@Biotechnology) experienced а +3.17% price change this week, while PRAX (@Biotechnology) price change was -12.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

PRAX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRAX($995M) has a higher market cap than OCS($929M). OCS YTD gains are higher at: 7.059 vs. PRAX (-38.578). OCS has higher annual earnings (EBITDA): -101.78M vs. PRAX (-232.71M). PRAX has more cash in the bank: 328M vs. OCS (182M). PRAX (1.07M) and OCS (1.1M) have identical debt. PRAX has higher revenues than OCS: PRAX (8.12M) vs OCS (0).
OCSPRAXOCS / PRAX
Capitalization929M995M93%
EBITDA-101.78M-232.71M44%
Gain YTD7.059-38.578-18%
P/E Ratio63.08N/A-
Revenue08.12M-
Total Cash182M328M55%
Total Debt1.1M1.07M103%
TECHNICAL ANALYSIS
Technical Analysis
OCSPRAX
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
51%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
51%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
65%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
50%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
49%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
71%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
63%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
45%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
OCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APDHX26.220.02
+0.08%
Artisan Global Equity Advisor
FADAX22.44N/A
N/A
Fidelity Advisor Dividend Growth A
JCVWX24.28N/A
N/A
JHancock Classic Value R6
AAEMX11.97N/A
N/A
Alger Emerging Markets A
VADFX76.90N/A
N/A
Invesco Equally-Wtd S&P 500 R6

OCS and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCS has been loosely correlated with CUE. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if OCS jumps, then CUE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCS
1D Price
Change %
OCS100%
N/A
CUE - OCS
35%
Loosely correlated
+3.45%
SNSE - OCS
32%
Poorly correlated
-6.97%
PRAX - OCS
29%
Poorly correlated
-2.74%
CGEN - OCS
29%
Poorly correlated
-1.37%
GRI - OCS
28%
Poorly correlated
-0.80%
More

PRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRAX has been loosely correlated with CDXS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRAX jumps, then CDXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRAX
1D Price
Change %
PRAX100%
-2.74%
CDXS - PRAX
49%
Loosely correlated
-2.80%
DNLI - PRAX
46%
Loosely correlated
-0.42%
MNMD - PRAX
46%
Loosely correlated
+1.01%
ABCL - PRAX
41%
Loosely correlated
+2.67%
OCUL - PRAX
39%
Loosely correlated
-1.60%
More